earnings
KR
NASDAQ · KROS
Keros Therapeutics, Inc.
Healthcare · Biotechnology
$9.36
Down-$0.19 (-2.03%)
Updated Nov 10, 2026, 12:35 AM
SID Score
4.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 878.88M
- P/E ratio
- 13.67
- Dividend yield
- 0.00%
- 52-week range
- $9.26 – $12.65
- Volume
- 192.04K
- Avg. volume
- 987.56K
Price performance · KROS
KROS price history
1M range · 0 trading sessions · Daily adjusted prices
KROS does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest KROS news
The latest Smart Investors Daily articles mentioning KROS.
Stock researchCompany · Overview
Company
Market Activity
Research & News
Loading stock research…